Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Médecine et Maladies Infectieuses Année : 2019

Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies

Résumé

OBJECTIVE: To compare the practices of French infection specialists related to antibiotic therapy duration between 2016 and 2018.METHODS: We conducted two identical surveys (in 2016 and 2018) targeting hospital-based infection specialists (medical physicians, pharmacists) who gave at least weekly advice on antibiotic prescriptions. The questionnaire included 15 clinical vignettes. Part A asked about the durations of antibiotic therapies they would usually advise to prescribers, and part B asked about the shortest duration they would be willing to advise for the same clinical situations.RESULTS: We included 325 specialists (165 in 2016 and 160 in 2018), mostly infectious disease specialists (82.4%, 268/325), members of antibiotic stewardship teams in 72% (234/325) of cases. Shorter antibiotic treatments (as compared with the literature) were advised to prescribers in more than half of the vignettes by 71% (105/147) of respondents in 2018, versus 46% (69/150) in 2016 (P<0.001). Guidelines used by participants displayed fixed durations for 77% (123/160) of cases in 2018 versus 21% (35/165) in 2016. Almost all respondents (89%, 131/160) declared they were aware of the 2017 SPILF's proposal.CONCLUSION: The release of guidelines promoting shorter durations of antibiotic therapy seems to have had a favourable impact on practices of specialists giving advice on antibiotic prescriptions.
Fichier principal
Vignette du fichier
S0399077X1830739X.pdf (408.29 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02459159 , version 1 (20-12-2021)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

G. Macheda, A. Luc, G. Béraud, B. Castan, R. Gauzit, et al.. Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies. Médecine et Maladies Infectieuses, 2019, 49 (6), pp.456-462. ⟨10.1016/j.medmal.2019.07.005⟩. ⟨hal-02459159⟩
95 Consultations
87 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More